Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Apr 15, 2026; 18(4): 115687
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.115687
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.115687
Table 4 Predictive value of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and carcinoembryonic antigen
| Indicator | AUC | Optimal cutoff | Youden index | Sensitivity (%) | Specificity (%) | 95%CI | P value |
| NLR | 0.896 | 4.01 | 0.7284 | 76.74 | 96.10 | 0.828-0.945 | < 0.0001 |
| PLR | 0.805 | 141.14 | 0.7544 | 76.74 | 98.70 | 0.723-0.872 | < 0.0001 |
| CEA | 0.880 | 15.49 | 0.6192 | 81.40 | 80.52 | 0.817-0.923 | < 0.0001 |
| Joint detection | 0.977 | 0.9118 | 97.67 | 93.51 | 0.931-0.996 | < 0.0001 |
- Citation: Wang T, Liu C, Jiang J. Clinical prediction of carcinoembryonic antigen combined with neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for postoperative survival in colorectal cancer. World J Gastrointest Oncol 2026; 18(4): 115687
- URL: https://www.wjgnet.com/1948-5204/full/v18/i4/115687.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i4.115687